Children, Infants & Newborns

Enfamil NeuroPro Study

This study will compare infant gut bacteria for infants who have been fed a standard infant formula (Enfamil Infant); infants who have been fed a new infant formula designed to be more similar to breast milk (Enfamil NeuroPro); and breastfed infants. These formulas are currently available on the market and meet FDA requirements for infant formula.

Primary disease category:

Secondary disease category(ies):

Digestive System

NGAM-13

A Superiority Study to Compare The Effect of Panzyga Versus Placebo in Patients with Pediatric Acute-onset Neuropsychiatric Syndrome

Primary disease category:

Allergy & Immunology

Secondary disease category(ies):

Children, Infants & Newborns

DETECT

A Research Study of How Well Macimorelin Works to Find Out if Children Have a Lack of Growth Hormone and How Safe it is (DETECT)

Primary disease category:

Diabetes & Endocrine System

Secondary disease category(ies):

Children, Infants & Newborns

FORSEE

This is a multi-center, open-label, single-arm study. All subjects will be pediatric patients with central precocious puberty judged to be candidates for GnRH (gonadotropin releasing hormone) analog therapy, and all will receive two injections of FP-001 42 mg six-month apart in an unblinded fashion.

Primary disease category:

Diabetes & Endocrine System

Secondary disease category(ies):

Children, Infants & Newborns

The Tapestry Autism Study

The University of Arizona Division of Developmental & Behavioral Pediatrics has partnered with Axial Therapeutics for a clinical trial to determine whether its investigational drug, AB-2004, is safe and effective in treating the symptoms of autism spectrum disorder in children ages 5-17. This 12-week randomized, double-blind, placebo-controlled study includes behavioral assessments and safety monitoring. Blood draws, urine and stool samples are required.

Primary disease category:

Child Development & Autism

Secondary disease category(ies):

Children, Infants & Newborns

Pathway to Prevention

TrialNet is an international network dedicated to the study, prevention, and early treatment of type 1 diabetes. TrialNet sites are located throughout the United States, Canada, Finland, United Kingdom, Italy, Germany, Sweden, Australia, and New Zealand. TrialNet is dedicated to testing new approaches to the prevention of and early intervention for type 1 diabetes.

Primary disease category:

Diabetes & Endocrine System

Secondary disease category(ies):

Children, Infants & Newborns

The role of gut microbiome in epilepsy

The propose of this pilot study is to test the hypothesis that children with epilepsy have changes in gut microbiome as compared to their siblings and controls.

Our specific aims are:

1. To compare the taxonomy of gut microbiome in patients with new onset epilepsy versus siblings and controls.

2. To compare the taxonomy of gut microbiome in patients with new onset epilepsy versus chronic and refractory epilepsy.

Primary disease category:

Children, Infants & Newborns

Secondary disease category(ies):

Brain, Spinal Cord & Nervous System, Epilepsy & Seizures, Children, Infants & Newborns, Healthy Volunteers

Nurtured Heart Approach Study

Parents or caregivers of a child with ADHD ages 6, 7 or 8 are invited to participate in a study to reduce ADHD symptoms. Parents are asked to complete surveys at two or three time points and to complete a six-week online course called the Nurtured Heart Approach.

Primary disease category:

Child Development & Autism

Secondary disease category(ies):

Children, Infants & Newborns

Family Routines Enhancing Adolescent Diabetes by Optimizing Management

We are looking for families with a child or adolescent with a diagnosis of type 1 diabetes to participate in a study examining the effects of an intervention to assist families with their daily routines. Assessments and the intervention consultation address sleep, school, and family activities that may help or interfere with diabetes management.

Primary disease category:

Diabetes & Endocrine System

Secondary disease category(ies):

Children, Infants & Newborns